Aveanna Healthcare (NASDAQ:AVAH) Upgraded at Wall Street Zen

Key Points

• Aveanna Healthcare has been upgraded from a "buy" rating to a "strong-buy" rating by Wall Street Zen, indicating increased analyst confidence in the company's stock.
• The company currently has a market capitalization of $1.20 billion and a PE ratio of 76.75, with a consensus rating of "Hold" and an average target price of $5.25.
• Insider trading reports show that major shareholder Robert M. Williams, Jr. sold over 1.5 million shares recently, reflecting a significant change in ownership levels within the company.

Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a research report issued on Saturday.

AVAH has been the subject of a number of other reports. Jefferies Financial Group raised Aveanna Healthcare from a "hold" rating to a "buy" rating and decreased their target price for the company from $6.25 to $6.00 in a research note on Monday, July 21st. Barclays initiated coverage on Aveanna Healthcare in a research note on Wednesday, July 2nd. They issued an "equal weight" rating and a $5.50 target price for the company. UBS Group boosted their target price on Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research note on Friday, May 9th. Finally, Truist Financial decreased their target price on Aveanna Healthcare from $6.00 to $5.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Aveanna Healthcare presently has a consensus rating of "Hold" and an average target price of $5.25.

Aveanna Healthcare Trading Up 5.7%

NASDAQ AVAH opened at $6.14 on Friday. The stock has a 50-day simple moving average of $4.61 and a 200 day simple moving average of $4.79. The company has a market capitalization of $1.20 billion, a PE ratio of 76.75 and a beta of 1.95. Aveanna Healthcare has a 12 month low of $3.67 and a 12 month high of $6.46.

Insider Activity at Aveanna Healthcare

In other news, major shareholder Robert M. Williams, Jr. sold 1,560,700 shares of the company's stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $5.36, for a total transaction of $8,365,352.00. Following the completion of the transaction, the insider directly owned 29,640,756 shares of the company's stock, valued at $158,874,452.16. This represents a 5.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Deborah Stewart sold 15,457 shares of the company's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $5.56, for a total value of $85,940.92. Following the transaction, the chief accounting officer directly owned 285,396 shares of the company's stock, valued at $1,586,801.76. This represents a 5.14% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 7,024,284 shares of company stock valued at $37,306,260 over the last ninety days. Company insiders own 7.80% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Banque Transatlantique SA acquired a new position in Aveanna Healthcare during the first quarter valued at approximately $25,000. BNP Paribas Financial Markets acquired a new position in Aveanna Healthcare during the fourth quarter valued at approximately $35,000. KLP Kapitalforvaltning AS acquired a new position in Aveanna Healthcare during the fourth quarter valued at approximately $35,000. Tower Research Capital LLC TRC boosted its position in Aveanna Healthcare by 662.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock valued at $36,000 after purchasing an additional 6,854 shares during the last quarter. Finally, Jump Financial LLC acquired a new position in Aveanna Healthcare during the first quarter valued at approximately $59,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.